CTOs on the Move

Galectin Therapeutics

www.galectintherapeutics.com

 
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company`s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Galectin Therapeutics raised $10M on 04/19/2021

Similar Companies

REM Associates

REM Associates is a Bonsall, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fluid Air

Fluid Air, Inc. is a Aurora, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rehab 2 Perform

R2P creates a unique physical therapy experience, offering our blend of performance, return to sport, physical therapy, dry needling and injury prevention.

Ionwerks

Ionwerks is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SSCI

SSCI is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.